Roche’s Acquisition Of TMEM16A Potentiator Portfolio

Goodwin Procter LLP advised Enterprise Therapeutics Ltd on the deal. Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now